Raymond James slashes price target on Cymabay Therapeutics Inc [CBAY] – find out why.
Cymabay Therapeutics Inc [NASDAQ: CBAY] jumped around 0.01 points on Thursday, while shares priced at $32.48 at the close of the session, up 0.03%. The company report on March 4, 2024 at 8:00 AM that CymaBay Announces European Medicines Agency Accepts for Review the Marketing